Replies to post #49370 on RespireRx Pharmaceuticals Inc (RSPI)

[Menace212]

They were otcqb back in 2021. Maybe they wish to receive that status again to help foster more deals.

[LTListener]

OTC Pink does not have those requirements to be audited. If things were looking down, they would just simply file simple forms and stay current. Uplisting has price requirements which they would have been established long before. Any OTC tier is not where this pipeline belongs anyways. It belongs where institutional can support throughout the phases of human clinicals. More likely would see M&A with assets on another exchange than simply uplist to QB/QX. In my opinion.

Rather they claim they are auditing financials and need independent auditors which would be a requirement to solidify a funding deal or any BP/M&A deal that includes equity, etc, etc. Many here I think agree if it was simply to stay pink current, this easily could be done. Something more is in the works, and would fit their timelines of moving the pipeline forward.

[crazy horse 0]

I like your thinking

OTCQB and OTCQX require that companies either register their securities with the SEC and have audited financial statements performed by a CPA audit firm that’s registered with the Public Company

So maybe they are looking to uplisting?